Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
Rush University, Chicago, Illinois Boston Children's Hospital, Boston, Massachusetts Seaver Autism Center at Mount Sinai, New York, New York